Granules India’s Gagillapur facility warrants regulatory action, the USFDA says
Granules India Ltd. has informed the exchanges on Tuesday, December 3, that the company’s Gagillapur facility in Telangana, has been classified as Official Action Indicated (OAI) by the United States Food and Drug Administration (USFDA). In September this year, the USFDA had issued a form 483 with six observations for the Gagillapur facility. An Official…